Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) FCF Margin (2016 - 2026)

Cumberland Pharmaceuticals' FCF Margin history spans 16 years, with the latest figure at 0.02% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 1821.0% to 0.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 10.86%, a 1265.0% increase, with the full-year FY2025 number at 10.86%, up 1265.0% from a year prior.
  • FCF Margin hit 0.02% in Q4 2025 for Cumberland Pharmaceuticals, down from 1.97% in the prior quarter.
  • Over the last five years, FCF Margin for CPIX hit a ceiling of 47.42% in Q2 2023 and a floor of 25.63% in Q1 2024.
  • Historically, FCF Margin has averaged 11.8% across 5 years, with a median of 11.17% in 2023.
  • Biggest five-year swings in FCF Margin: crashed -5618bps in 2024 and later surged 5851bps in 2025.
  • Tracing CPIX's FCF Margin over 5 years: stood at 23.45% in 2021, then skyrocketed by 77bps to 41.56% in 2022, then plummeted by -74bps to 10.6% in 2023, then surged by 72bps to 18.23% in 2024, then tumbled by -100bps to 0.02% in 2025.
  • Business Quant data shows FCF Margin for CPIX at 0.02% in Q4 2025, 1.97% in Q3 2025, and 7.54% in Q2 2025.